# Elevance Health, Inc.: filings

ELV · NYSE · CIK 1156039 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/elv.md) · [Financials](/companies/elv/financials.md) · [Filings](/companies/elv/filings.md) · [Insiders](/companies/elv/insiders.md)

## Reports and events: 353 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 800, 8-K 258, 425 57, 10-Q 54, 3 40, SC 13G/A 38, DEFA14A 27, 424B3 24, 144 21, 11-K 20, FWP 20, DEF 14A 19, 10-K 18, UPLOAD 14, SC 13G 12, NO ACT 11, CORRESP 10, 424B5 9, ARS 7, PRE 14A 6, 424B2 5, PX14A6G 5, S-3ASR 5, S-8 4, SCHEDULE 13G/A 3, 10-Q/A 2, 4/A 2, 8-K/A 2, S-8 POS 2, 25-NSE 1, 3/A 1, 424B7 1, 5 1, 8-A12B 1, CERTNYS 1, EFFECT 1, POSASR 1, RW 1, S-4 1, S-4/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 18:14 ET | [10-Q](/filings/0001156039-26-000071.md) | Quarterly report, period 2026-09-30 | 0001156039-26-000071 |
| 2026-10-21 | 10:01 ET | [8-K](/filings/0001156039-26-000068.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-26-000068 |
| 2026-09-10 | 10:00 ET | [8-K](/filings/0001156039-26-000063.md) | 7.01 Regulation FD disclosure | 0001156039-26-000063 |
| 2026-07-15 | 15:27 ET | [10-Q](/filings/0001156039-26-000060.md) | Quarterly report, period 2026-06-30 | 0001156039-26-000060 |
| 2026-07-15 | 10:01 ET | [8-K](/filings/0001156039-26-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-26-000058 |
| 2026-06-10 | 10:01 ET | [8-K](/filings/0001156039-26-000049.md) | 7.01 Regulation FD disclosure | 0001156039-26-000049 |
| 2026-05-13 | 20:07 ET | [8-K](/filings/0001156039-26-000046.md) | 5.07 Shareholder vote results | 0001156039-26-000046 |
| 2026-04-22 | 14:09 ET | [10-Q](/filings/0001156039-26-000043.md) | Quarterly report, period 2026-03-31 | 0001156039-26-000043 |
| 2026-04-22 | 10:02 ET | [8-K](/filings/0001156039-26-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-26-000039 |
| 2026-03-27 | 20:21 ET | [DEF 14A](/filings/0001156039-26-000031.md) | Proxy statement, period 2026-05-13 | 0001156039-26-000031 |
| 2026-03-10 | 10:02 ET | [8-K](/filings/0001156039-26-000024.md) | 7.01 Regulation FD disclosure | 0001156039-26-000024 |
| 2026-03-02 | 11:03 ET | [8-K](/filings/0001156039-26-000022.md) | 8.01 Other events | 0001156039-26-000022 |
| 2026-02-26 | 19:59 ET | [8-K](/filings/0001156039-26-000019.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001156039-26-000019 |
| 2026-02-06 | 19:57 ET | [10-K](/filings/0001156039-26-000013.md) | Annual report, period 2025-12-31 | 0001156039-26-000013 |
| 2026-01-28 | 11:03 ET | [8-K](/filings/0001156039-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-26-000006 |
| 2025-12-10 | 21:35 ET | [8-K](/filings/0001156039-25-000142.md) | 5.02 Departure or appointment of officers or directors | 0001156039-25-000142 |
| 2025-11-10 | 22:03 ET | [8-K](/filings/0001156039-25-000139.md) | 7.01 Regulation FD disclosure | 0001156039-25-000139 |
| 2025-10-21 | 15:11 ET | [10-Q](/filings/0001156039-25-000136.md) | Quarterly report, period 2025-09-30 | 0001156039-25-000136 |
| 2025-10-21 | 10:01 ET | [8-K](/filings/0001193125-25-244191.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-244191 |
| 2025-09-15 | 20:05 ET | [8-K](/filings/0001193125-25-203542.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-203542 |
| 2025-09-04 | 10:02 ET | [8-K](/filings/0001156039-25-000129.md) | 7.01 Regulation FD disclosure | 0001156039-25-000129 |
| 2025-07-28 | 20:38 ET | [8-K](/filings/0001156039-25-000118.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001156039-25-000118 |
| 2025-07-17 | 19:09 ET | [10-Q](/filings/0001156039-25-000114.md) | Quarterly report, period 2025-06-30 | 0001156039-25-000114 |
| 2025-07-17 | 10:03 ET | [8-K](/filings/0001156039-25-000111.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-25-000111 |
| 2025-05-28 | 10:31 ET | [8-K](/filings/0001156039-25-000096.md) | 7.01 Regulation FD disclosure | 0001156039-25-000096 |
| 2025-05-14 | 21:27 ET | [8-K](/filings/0001156039-25-000065.md) | 5.07 Shareholder vote results | 0001156039-25-000065 |
| 2025-04-22 | 17:18 ET | [10-Q](/filings/0001156039-25-000057.md) | Quarterly report, period 2025-03-31 | 0001156039-25-000057 |
| 2025-04-22 | 10:05 ET | [8-K](/filings/0001156039-25-000056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-25-000056 |
| 2025-04-17 | 14:24 ET | [8-K](/filings/0001156039-25-000051.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001156039-25-000051 |
| 2025-03-28 | 20:20 ET | [DEF 14A](/filings/0001156039-25-000046.md) | Proxy statement, period 2025-05-14 | 0001156039-25-000046 |
| 2025-03-10 | 20:17 ET | [8-K](/filings/0001193125-25-050889.md) | 7.01 Regulation FD disclosure | 0001193125-25-050889 |
| 2025-02-20 | 20:58 ET | [10-K](/filings/0001156039-25-000010.md) | Annual report, period 2024-12-31 | 0001156039-25-000010 |
| 2025-01-23 | 11:03 ET | [8-K](/filings/0001156039-25-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-25-000007 |
| 2024-10-31 | 20:15 ET | [8-K](/filings/0001193125-24-248691.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-248691 |
| 2024-10-17 | 21:01 ET | [10-Q](/filings/0001156039-24-000122.md) | Quarterly report, period 2024-09-30 | 0001156039-24-000122 |
| 2024-10-17 | 10:02 ET | [8-K](/filings/0001156039-24-000119.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-24-000119 |
| 2024-07-17 | 19:01 ET | [10-Q](/filings/0001156039-24-000104.md) | Quarterly report, period 2024-06-30 | 0001156039-24-000104 |
| 2024-07-17 | 10:09 ET | [8-K](/filings/0001156039-24-000101.md) | 2.02 Results of operations | 0001156039-24-000101 |
| 2024-06-12 | 10:07 ET | [8-K](/filings/0001156039-24-000093.md) | 7.01 Regulation FD disclosure | 0001156039-24-000093 |
| 2024-05-30 | 20:45 ET | [8-K](/filings/0001193125-24-150440.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-150440 |
| 2024-05-15 | 21:14 ET | [8-K](/filings/0001156039-24-000069.md) | 5.07 Shareholder vote results | 0001156039-24-000069 |
| 2024-04-18 | 18:16 ET | [10-Q](/filings/0001156039-24-000066.md) | Quarterly report, period 2024-03-31 | 0001156039-24-000066 |
| 2024-04-18 | 10:07 ET | [8-K](/filings/0001193125-24-099824.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-099824 |
| 2024-03-29 | 20:08 ET | [DEF 14A](/filings/0001156039-24-000050.md) | Proxy statement, period 2024-05-15 | 0001156039-24-000050 |
| 2024-03-04 | 11:07 ET | [8-K](/filings/0001193125-24-056688.md) | 7.01 Regulation FD disclosure | 0001193125-24-056688 |
| 2024-02-21 | 21:30 ET | [10-K](/filings/0001156039-24-000015.md) | Annual report, period 2023-12-31 | 0001156039-24-000015 |
| 2024-01-25 | 22:20 ET | [8-K](/filings/0001193125-24-015557.md) | 8.01 Other events | 0001193125-24-015557 |
| 2024-01-24 | 11:04 ET | [8-K](/filings/0001193125-24-013498.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-013498 |
| 2023-10-18 | 18:43 ET | [10-Q](/filings/0001156039-23-000109.md) | Quarterly report, period 2023-09-30 | 0001156039-23-000109 |
| 2023-10-18 | 10:05 ET | [8-K](/filings/0001193125-23-258013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-258013 |

Page 1 of 8. [Older](/companies/elv/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.